Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market
Holding INBX?
Track your performance easily

Inhibrx Biosciences Inc (INBX) Financial Statements

16 Followers

Inhibrx Biosciences Inc Financial Overview

Inhibrx Biosciences Inc's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Inhibrx Biosciences Inc is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-3.60. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 1.63M$ 119.00K$ 30.00K$ 17.00K
Gross Profit-$ 1.63M$ 119.00K$ 30.00K$ 17.00K
EBIT$ -49.27M-$ -51.79M$ -47.05M$ -48.92M
EBITDA$ -48.91M---$ -47.42M
Net Income Common Stockholders$ -49.27M$ -93.60M$ -51.79M$ -47.05M$ -48.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 277.92M$ 337.33M$ 192.49M$ 234.30M
Total Assets$ 28.22M$ 307.89M$ 372.73M$ 213.17M$ 253.72M
Total Debt$ 2.68M$ 210.14M$ 209.38M$ 208.61M$ 207.85M
Net Debt$ 2.68M$ -67.78M$ -127.95M$ 16.12M$ -26.45M
Total Liabilities$ 38.99M$ 264.39M$ 243.14M$ 237.98M$ 238.58M
Stockholders Equity$ -10.77M$ 43.50M$ 129.59M$ -24.81M$ 15.13M
Cash Flow-
Free Cash Flow$ -41.43M---$ -39.97M
Operating Cash Flow$ -40.31M$ -56.82M$ -54.24M$ -42.30M$ -39.94M
Investing Cash Flow$ -1.12M$ -3.44M$ -811.00K$ -317.00K$ -23.00K
Financing Cash Flow$ 41.43M$ 860.00K$ 199.89M$ 854.00K$ 356.00K
Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History

Inhibrx Biosciences Inc Debt to Assets

Inhibrx Biosciences Inc Cash Flow

Inhibrx Biosciences Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis